Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07499674
Recruiting
Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
Phase 3 · Australia, United States · 9 sites
Registry update: 2 Nov 2026
NCT07361276
Recruiting
Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care System
Not applicable · Brazil · 1 site
Registry update: 22 Oct 2026
NCT07425769
Recruiting
Adapting RDAD for DS
Not applicable · United States · 1 site
Registry update: 3 Aug 2026
NCT07465263
Recruiting
A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
Phase 3 · China · 1 site
Registry update: 8 Jul 2026
NCT07191119
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
Not applicable · United States · 1 site
Registry update: 14 Aug 2026
NCT07556887
Recruiting
Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation
Not applicable · Netherlands · 10 sites
Registry update: 15 May 2026
NCT07542652
Recruiting
Association Between Microplastic Exposure and the Pathological Progression of Gastric Carcinogenesis
Not applicable · China · 1 site
Registry update: 30 Apr 2026
NCT07407933
Recruiting
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
Phase 1/2 · Belgium, Spain, France, United Kingdom, Hungary, Italy, Poland, Romania, United States · 38 sites
Registry update: 17 Sept 2026
NCT07454642
Recruiting
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Phase 1 · United States · 7 sites
Registry update: 5 Oct 2026
NCT07610538
Recruiting
Low-dose Interleukin-2 After Myocardial Infarction to Investigate Effects on Tissue-resident Regulatory T Cells
Not applicable · United Kingdom · 2 sites
Registry update: 28 May 2026
2025-522338-30-00
Recruiting
LY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study
Phase 2 · Austria, Germany, Denmark, Spain, Hungary, Italy, Netherlands, Poland, Romania · 42 sites
Registry update: 7 Oct 2026
NCT07382739
Recruiting
A Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Multiple Myeloma (RRMM) With Extramedullary Disease (EMD) and Paramedullary Disease (PMD) "PRIME-EMD-PMD"
Phase 2 · United States · 1 site
Registry update: 18 Sept 2026
NCT07478185
Recruiting
Prehab for Pancreatic Cancer Surgery
Not applicable · United States · 1 site
Registry update: 3 Apr 2026
NCT07398339
Recruiting
Cosiporfin Sodium for Injection Photodynamic Therapy
Phase 2 · China · 1 site
Registry update: 9 Feb 2026
NCT07234981
Recruiting
PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer
Phase 2 · United States · 1 site
Registry update: 21 Sept 2026
NCT06282952
Recruiting
Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation
Not applicable · Finland · 1 site
Registry update: 21 Jul 2026
NCT07523620
Recruiting
Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration
Not applicable · Belgium, Czechia, Germany, Denmark, Spain, United Kingdom, Ireland, Italy, Lithuania, Poland · 16 sites
Registry update: 23 Oct 2026
NCT07504276
Recruiting
Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors.
Not applicable · Pakistan · 1 site
Registry update: 3 Apr 2026
NCT07589205
Recruiting
Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors
Phase 1 · China · 1 site
Registry update: 23 Jul 2026
NCT07515014
Recruiting
A Study of E6742 in Participants With Systemic Lupus Erythematosus
Phase 2 · China, Japan, South Korea, Taiwan · 54 sites
Registry update: 21 Aug 2026

Ordered by registry start date. Freshness and sponsorship never change the order.